Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.

Am J Surg Pathol. 2012 Jul;36(7):945-54. doi: 10.1097/PAS.0b013e318253a2d1.

PMID:
22743284
2.

Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.

Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M.

Int J Cancer. 2017 Mar 1;140(5):1186-1198. doi: 10.1002/ijc.30516. Epub 2016 Dec 2. Review.

PMID:
27859245
3.

From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.

Boscolo-Rizzo P, Pawlita M, Holzinger D.

Cancer Treat Rev. 2016 Jan;42:24-9. doi: 10.1016/j.ctrv.2015.10.009. Epub 2015 Oct 31. Review.

PMID:
26547133
4.

What are the implications of human papillomavirus status in oropharyngeal tumors for clinical practice?

Klozar J, Tachezy R.

Curr Opin Otolaryngol Head Neck Surg. 2014 Apr;22(2):90-4. doi: 10.1097/MOO.0000000000000030. Review.

PMID:
24492854
5.

HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.

Bishop JA, Lewis JS Jr, Rocco JW, Faquin WC.

Semin Diagn Pathol. 2015 Sep;32(5):344-51. doi: 10.1053/j.semdp.2015.02.013. Epub 2015 Feb 4. Review.

PMID:
25724476
6.

Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know.

Mirghani H, Amen F, Moreau F, Guigay J, Ferchiou M, Melkane AE, Hartl DM, Lacau St Guily J.

Oral Oncol. 2014 Jan;50(1):1-9. doi: 10.1016/j.oraloncology.2013.10.008. Epub 2013 Oct 26. Review.

PMID:
24169585
7.

Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.

Masand RP, El-Mofty SK, Ma XJ, Luo Y, Flanagan JJ, Lewis JS Jr.

Head Neck Pathol. 2011 Jun;5(2):108-16. doi: 10.1007/s12105-011-0245-3. Epub 2011 Feb 9. Review.

8.

Laryngeal Cancer, HPV DNA vs E6/E7 mRNA Test: A Systematic Review.

Fusconi M, Campo F, Gallo A, Zambetti G, Martellucci S, Seccia A, de Vincentiis M.

J Voice. 2017 Mar;31(2):248.e1-248.e5. doi: 10.1016/j.jvoice.2016.08.002. Epub 2016 Sep 6. Review.

PMID:
27613249
9.

Is p16 an adequate surrogate for human papillomavirus status determination?

Jouhi L, Hagström J, Atula T, Mäkitie A.

Curr Opin Otolaryngol Head Neck Surg. 2017 Apr;25(2):108-112. doi: 10.1097/MOO.0000000000000341. Review.

PMID:
28141601
10.

What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?

Urban D, Corry J, Rischin D.

Cancer. 2014 May 15;120(10):1462-70. doi: 10.1002/cncr.28595. Epub 2014 Feb 27. Review.

11.

Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.

Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué X.

Vaccine. 2012 Nov 20;30 Suppl 5:F34-54. doi: 10.1016/j.vaccine.2012.05.070. Review.

PMID:
23199965
12.

Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing.

Robinson M, Sloan P, Shaw R.

Oral Oncol. 2010 Jul;46(7):492-6. doi: 10.1016/j.oraloncology.2010.02.013. Epub 2010 Mar 12. Review.

PMID:
20227331
13.

P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects.

Wang H, Sun R, Lin H, Hu WH.

Cancer Sci. 2013 Dec;104(12):1553-9. doi: 10.1111/cas.12287. Epub 2013 Nov 8. Review.

14.

HPV-positive head and neck tumours, a distinct clinical entity.

Nevens D, Nuyts S.

B-ENT. 2015;11(2):81-7. Review.

PMID:
26563006
15.

p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma.

Lewis JS Jr.

Head Neck Pathol. 2012 Jul;6 Suppl 1:S75-82. doi: 10.1007/s12105-012-0369-0. Epub 2012 Jul 3. Review.

16.

HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients.

Robinson M, Schache A, Sloan P, Thavaraj S.

Head Neck Pathol. 2012 Jul;6 Suppl 1:S83-90. doi: 10.1007/s12105-012-0370-7. Epub 2012 Jul 3. Review.

17.

Role of human papillomavirus in non-oropharyngeal head and neck cancers.

Combes JD, Franceschi S.

Oral Oncol. 2014 May;50(5):370-9. doi: 10.1016/j.oraloncology.2013.11.004. Epub 2013 Dec 9. Review.

PMID:
24331868
18.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Marur S, D'Souza G, Westra WH, Forastiere AA.

Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Review.

19.

Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.

Ihloff AS, Petersen C, Hoffmann M, Knecht R, Tribius S.

Oral Oncol. 2010 Oct;46(10):705-11. doi: 10.1016/j.oraloncology.2010.07.006. Epub 2010 Sep 16. Review.

PMID:
20843732
20.

Current trends in the etiology and diagnosis of HPV-related head and neck cancers.

Chai RC, Lambie D, Verma M, Punyadeera C.

Cancer Med. 2015 Apr;4(4):596-607. doi: 10.1002/cam4.424. Epub 2015 Feb 1. Review.

Supplemental Content

Support Center